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INTRODUCTION
In the wake of the 2009 influenza pandemic A(H1N1), several studies linked obesity and/or morbid obesity to adverse
outcomes like hospitalization [1], longer length of stay in intensive care unit (ICU) [2], and death [1, 3]. Despite strong
evidence of a link between morbid obesity and adverse outcomes due to 2009 H1N1 flu, it remains unclear whether
there is an association between obesity and influenza‐related complications for influenza strains outside of H1N1, such
as seasonal influenza [4].
Kwong and colleagues were the first to suggest a link between obesity and seasonal influenza in a cohort study over 12
influenza seasons in Canada [5]. The study found that adults classified as obese class I (body mass index [BMI] 30‐34.9
units) and obese class II or III (BMI ≥35 units) had increased odds of hospitalization for respiratory disease during
influenza seasons, compared to adults of normal weight [5]. However, Kwong and colleagues’ study has two major
limitations: use of self‐reported BMI and selection of respiratory illness as an outcome [5]. Self‐reported BMI may
include incorrectly reported values [6], and respiratory illness outcomes may include cases that were hospitalized for
causes other than influenza.
Few studies since have explored the association between obesity and seasonal influenza and those that have, have done
so with conflicting results. While Cocoros and colleagues [7] found evidence of increased odds of hospitalization for
influenza‐like illness (ILI) in adults compared to adults of normal weight, Coleman and colleagues [8] reported no
association between obesity and medically attended laboratory‐confirmed influenza. The inconsistent results may be
explained by Cocoros and colleagues’ use of hospitalization as an outcome, while Coleman and colleagues studied
laboratory‐confirmed influenza as an outcome [7, 8]. Cocoros and colleagues were limited by the use of ILI as an
outcome, instead of laboratory‐confirmed influenza [7]. Coleman and colleagues interpreted their finding of no
association by noting that “the risk factors for severe complications of influenza‐associated illnesses may be
fundamentally different from those for less severe, non‐hospitalized influenza” [8].
In this study, we address some of the shortcomings of previous research on the possible link between obesity and
influenza outcomes. Our study is, to our knowledge, the first to use laboratory‐confirmed flu from a large national
database to explore the association between obesity and severe outcomes among patients hospitalized for seasonal
influenza. We examine the odds of receiving artificial ventilation procedure, admission to intensive care unit (ICU), and
X‐ray confirmed pneumonia diagnosis among hospitalized obese and morbidly obese adults compared to adults of
normal weight. We control for several demographic and clinical characteristics, including influenza‐related
comorbidities and influenza vaccination status.
METHODS
Surveillance for Influenza‐Associated Hospitalizations
We used data from the Centers for Disease Control’s (CDC) Influenza Hospitalization Surveillance Project database,
FluSurv‐NET, gathered from October 1, 2012, to April 30, 2013 [9]. FluSurv‐NET is a hospital surveillance program for
laboratory‐confirmed, influenza‐related hospitalizations collected from participating hospitals in 81 counties in 10
states: California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and
Tennessee [9]. Emerging Infections Program sites in each of the 10 states complete Case Report Forms that are
completed via medical chart review of medical records from participating hospitals [9]. Case Report Forms are then sent
to the Centers for Disease Control and Prevention for aggregation [9].
Case Definition

We defined a case as an individual who tested positive for laboratory‐confirmed influenza. Laboratory‐confirmed
influenza is defined as positive test result by viral culture, direct or indirect fluorescent antibody staining, a rapid
diagnostic test, serologic testing (4‐fold increase in titer), or a positive specified test indicated in the medical record.
Cases were admitted to a hospital within 14 days of positive influenza test.
Body Mass Index
We determined BMI values for cases in the FluSurv‐NET dataset by calculating BMI = weight (in kg) / height (in m)2 using
weight and height from a case’s medical record. Because the CDC indicates that BMI categorization for individuals less
than 20 years of age is different than BMI categorization for individuals greater than or equal to 20 years of age [10], we
excluded 49 cases <20 years of age from our dataset. Pregnant women were also excluded from our analysis.
We calculated BMI for 9014 cases using weight and height abstracted from medical records. For cases where BMI could
not be calculated because of missing height and/or weight values in our dataset, BMI abstracted from the medical
record was used if available; 37 cases had missing calculated BMI replaced by BMI abstracted from medical record. For
14 cases with extreme values of calculated BMI, i.e. BMI ≥ 100 or BMI ≤ 10, BMI abstracted from medical record was
used, if available; in all but 3 cases, extreme BMI values were replaced with BMI abstracted from medical record. In
total, there were 778 cases with missing BMI value due to one of the following two conditions: 1) the case had extreme
value of BMI (see definition of extreme value above) and no BMI from medical record available, or 2) height and/or
weight was missing and BMI from the medical record was missing. Cases with missing BMI values were excluded from
the analysis, resulting in a sample size of 9048.
We classified BMI into one of five categories: underweight (BMI <18.5), normal (BMI 18.5 to <25), overweight (BMI 25 to
<30), obese (BMI 30 to <35), and morbidly obese (BMI ≥35).
Main Outcome Measures
We explored the relationship between obesity and three severe flu outcomes: artificial ventilation, ICU admission, and
X‐ray confirmed pneumonia. We defined artificial ventilation as a case that received either mechanical ventilation
procedure or extracorporeal membrane oxygenation (ECMO). ICU admission includes but is not limited to: medical ICU,
surgical ICU, and cardiac care unit. ICU admission excludes admission to a step‐down unit or transitional care unit. X‐ray
confirmed pneumonia was determined using chest X‐ray results. If chest X‐ray results concluded one of the following,
the subject was determined to have confirmed pneumonia: bronchopneumonia/pneumonia, air space density/opacity,
pleural effusion, or multiple lobar infiltrate (unilateral or bilateral).
Covariates
Covariates were selected from one of four broad categories: demographic characteristics, comorbidities, lifestyle
factors, and patient care factors that may be associated with severe influenza outcomes and/or BMI category. Our
criteria for selection of covariates were comorbidities recognized by the Advisory Committee on Immunization Practices
as risk factors for influenza [11], lifestyle factors associated with BMI and/or influenza outcome, demographic
characteristics (age, sex, race), and patient care factors. Data for these variables were abstracted by trained medical
chart reviewers at Emerging Infections Program centers across the US. Medical chart reviewers abstracted data directly
from clinician’s notes in patient’s medical record using a well‐defined procedure outlined in Case Report Form
Instructions, Version 8, an instruction manual produced by the CDC [12].
Demographic Characteristics

The selected demographic characteristics we controlled for were age, sex, and race. Age was classified into 5 categories:
20 to <50, 50 to <65, 65 to <75, 75 to <85, and 85+. Race was abstracted from medical records in seven categories:
white, black, American Indian or Alaska Native, Asian/Pacific Islander, multiracial, Latino, and unknown. We reclassified
these categories into 4 new categories: white, black, Latino, and other/unknown to ensure a sufficient number of
subjects in each race category to perform statistical analyses. Our other/unknown category combined cases classified
on medical record as American Indian or Alaska Native, Asian/Pacific Islander, and unknown.
Comorbidities
The selected comorbidities we controlled for were cardiovascular disease (CVD), chronic metabolic disease (CMD),
neuromuscular disorder, neurologic disorder, immunocompromised condition, renal disease, and asthma. We defined
CVD by indication of one or more of the following conditions on the patient’s medical record: aortic aneurysm, aortic
stenosis, atherosclerotic cardiovascular disease, atrial fibrillation, cardiomyopathy, cerebral vascular incident/stroke,
congenital cardiac anomaly, congenital heart disease, coronary artery disease, heart failure/CHF, ischemic
cardiomyopathy, or non‐ischemic cardiomyopathy. We defined CMD as presence of diabetes and/or thyroid disease on
patient’s medical record. We defined neuromuscular disorder by indication of at least one of the following conditions
on patient’s medical record: Duchenne muscular dystrophy, muscular dystrophy, multiple sclerosis, mitochondrial
disorder, myasthenia gravis, or other specified conditions such as Parkinson’s disease and myasthenia gravis. We
defined neurologic disorder by indication of one of the following conditions on patient’s medical record: cerebral palsy,
cognitive dysfunction, dementia, development delay, Down syndrome, plegias/paralysis, seizure/seizure disorder, or
other related conditions that include schizophrenia and spinal cord injuries. We defined immunocompromised
condition by indication at least of one of the following conditions on patient’s medical record: AIDS or CD4 count <200,
cancer diagnosis in last 12 months, complement deficiency, HIV infection, immunoglobulin deficiency,
immunosuppressive therapy (e.g. chemotherapy), organ transplant, stem cell transplant, steroid therapy, or other
specified conditions such as lupus. We defined renal disease by indication of one of the following conditions on
patient’s medical record: chronic kidney disease/chronic renal insufficiency, end stage renal disease/dialysis,
glomerulonephritis, or nephrotic syndrome. We defined asthma by indication of asthma or Reactive Airway Disease
(RAD) on patient’s medical record.
Lifestyle Factors
The selected lifestyle factors we controlled for were alcohol abuse, smoking status, and influenza vaccination status. We
defined three categories of alcohol abuse: “current” if the patient quit abusing alcohol in the past 12 months or if no
time frame is given, “former” if the patient quit abusing alcohol more than 12 months ago, and “non‐abuser” if there
was no indication of alcohol abuse, dependency, or alcoholism on the patient’s medical record. We defined three
categories of tobacco “smoker”: “current” if the patient quit smoking tobacco in the past 12 months or if no time frame
is given, “former” if the patient quit smoking tobacco more than 12 months ago, and “non‐smoker” if there was no
indication of smoking tobacco on the patient’s medical record.
Patient Care Factors
Antiviral administration in the hospital was classified into 3 categories: “prompt” for patients who received antivirals the
same day that they were admitted to the hospital, “late” for patients who received antivirals between day 2 and up to
and including day 5 in the hospital, “none” for patients who received antivirals after day 5 in hospital or no antivirals at
all. We classified vaccination into two categories: patients who were vaccinated during the fall or winter of the 2012‐
2013 influenza season and patients who were not vaccinated during this period. Vaccinated subjects typically receive
protection against influenza from antibodies that develop during the body’s response to the influenza vaccine [8].

Statistical Analyses
We performed a bivariate analysis using the chi‐square test of homogeneity to determine whether, for a given covariate,
the frequency of cases was distributed identically across our five BMI categories. To evaluate whether there is an
association between obesity and/or morbid obesity and severe flu outcomes, we used logistic regression models with
logit link function to calculate the odds of having a severe flu outcome for each of our five BMI categories. For each of
three selected flu outcomes – artificial ventilation, ICU admission, and X‐ray confirmed pneumonia – we ran unadjusted,
sex‐ and age‐adjusted, and fully‐adjusted (for all covariates of interest) models. We selected the normal weight BMI
category (BMI greater than 10 but less than 25) as the reference group for all models. We produced odds ratio point
estimates, 95% Wald confidence limits, and associated p‐values for each of the five BMI categories for our three
outcome variables. SAS Version 9.3 was used for all statistical analyses [13].
RESULTS
This study included 9048 cases with laboratory‐confirmed influenza. Table 1 shows characteristics of the study
population. The mean and standard deviation of the age of cases was 68.3 ± 18.3 years. The majority of subjects were
aged 50 or above, with only 16.5% of cases under 50 years old. 413 (4.6%) cases were underweight, 2847 (31.5%) were
normal weight, 2701 (29.9%) were overweight, 1526 (16.9%) were obese, and 1561 (17.3%) were morbidly obese.
Overall, the frequency of cases in each age group was evenly distributed. However, when stratifying age by BMI
category, the majority of cases in the underweight category (31.0%) and normal weight category (31.8%) were 85+,
while the majority of cases in the obese (26.3%) and morbidly obese (33.1%) categories were 50‐64. Slightly more than
half (53.8%) of our study population was female, and the distribution of males versus females for normal, overweight,
and obese BMI groups was relatively even. However, there was a larger percentage of females than males in the
underweight (65.6% female) and morbidly obese (63.4%) BMI categories.
The distribution of race was also similar across BMI categories. The distribution of current, former, and non‐smokers
was similar across BMI categories. The percentage of cases with chronic metabolic disease (CMD) increased as BMI
category increased, while the percentages of cases with neurologic disorder, neuromuscular disorder, and
immunosuppressive condition decreased as BMI category increased. The timing of antiviral administration was similarly
distributed across BMI categories, with the majority of cases receiving prompt antiviral administration within one day of
admission. A larger percentage of cases in the normal weight category (57.5%) received influenza vaccine compared to
the morbidly obese category (46.5%).
Artificial Ventilation
There were 562 cases (6.2%) who received artificial ventilation. Unadjusted odds ratios (shown in Table 2) for artificial
ventilation of obese and morbidly obese cases compared to normal weight cases were not significantly different from 1
(OR = 1.03, 95% CI = 0.80, 1.33, p=0.9789; OR=1.14, 95% CI = 0.89, 1.46, p=0.3030). Adjusting for all clinical and
demographic characteristics did not reveal a significant association between obesity status and artificial ventilation. For
overweight cases compared to normal weight cases, odds ratios for the unadjusted, age‐ and sex‐adjusted, and fully‐
adjusted models were all protective, but non‐significant (OR = 0.91, 95% CI = 0.72, 1.13, p=0.3828; OR = 0.86, 95% CI =
0.69, 1.08, p=0.1486; OR = 0.87, 95% CI = 0.68, 1.12, p=0.2796).
Intensive Care Unit
There were 1396 cases (15.5%) who were admitted to the ICU. Unadjusted odds ratios (shown in Table 4) for ICU
admission among obese and morbidly obese cases compared to normal weight cases were not significant (OR=0.906,
95% CI 0.763 to 1.077, p=0.7374; OR=0.913, 95% CI 0.768 to 1.085, p=0.8780). Adjusting for sex and age did not reveal a

significant association between obesity or morbid obesity and ICU admission. The odds ratios for the fully‐adjusted
model revealed a non‐significant protective effect of obesity and morbid obesity on ICU admission (OR = 0.89, 95% CI =
0.74, 1.07, p=0.2282; OR = 0.86, 95% CI = 0.71, 1.04, p=0.1109). There was a significant protective effect of overweight
on ICU admission compared to normal weight group, after adjusting for all covariates in Table 1 (OR = 0.79, 95% CI =
0.67, 0.92, p=0.0036).
X‐Ray Confirmed Pneumonia
There were 2854 cases (32.6%) with X‐ray confirmed pneumonia. Unadjusted odds ratios (shown in Table 3) for X‐ray
confirmed pneumonia among obese and morbidly obese cases compared to normal weight cases were significantly less
than 1 (OR = 0.73, 95% CI = 0.64, 0.84, p=0.0002; OR = 0.72, 95% CI = 0.63, 0.83, p<.0001). Adjusting for sex and age
revealed a similar association of obesity and morbid obesity with X‐ray confirmed pneumonia. After adjusting for all
clinical and demographic characteristics, there was a significantly protective effect for odds of X‐ray confirmed
pneumonia for overweight compared to normal weight and obese compared to normal weight (OR = 0.87, 95% CI = 0.77,
0.98, p=0.0217; OR = 0.80, 95% CI = 0.69, 0.92, p=0.0023). The odds of X‐ray confirmed pneumonia among morbidly
obese compared to normal weight was protective, but non‐significant (OR = 0.89, 95% CI = 0.76, 1.04, p=0.1353).
DISCUSSION
We found no association between obesity (BMI from 30‐34.99) or morbid obesity (BMI ≥ 35) and severe seasonal flu
outcomes among adults hospitalized during the 2012‐2013 influenza season, after controlling for comorbidities,
demographic characteristics, lifestyle factors, and patient care factors. We did find significantly reduced adjusted odds
of X‐ray confirmed pneumonia for both obese and morbidly obese compared to normal weight. These apparent
protective effects were remained significant for obese cases, even after adjusting for all covariates. We found a
significantly protective effect of overweight compared to normal weight for ICU admission outcome and X‐ray confirmed
pneumonia, for unadjusted, sex‐ and age‐adjusted, and fully‐adjusted models. Our results add to a growing body of
research exploring the association between obesity and severe outcomes during influenza seasons where non‐pandemic
flu strains are dominant.
Our findings that obesity and morbid obesity are not associated with odds of artificial ventilation or ICU admission
suggest that once an adult is admitted to the hospital, obesity does not affect the level of severity of patients. Age, sex,
and other pre‐existing comorbidities may explain the majority of variation in adverse outcomes, while BMI may play an
insignificant role in explaining variation in adverse outcomes among patients. Another possible explanation of our
findings that obesity and morbid obesity are not associated with increased odds of artificial ventilation or ICU admission
is that obese patients may be “more likely to be admitted to hospital, even with milder disease” [15]. This could lead to
a larger proportion of obese subjects with less severe outcomes compared to normal weight subjects, resulting in a
finding of no or a protective effect of obesity on severe seasonal flu outcomes.
We suggest two possible explanations for our finding of significant protective effect of overweight and obesity for X‐ray
confirmed pneumonia. The first is that overweight and obesity may offer a protective effect for pneumonia. This result
would provide evidence in favor of the obesity paradox, a phenomenon that has been observed among patients with
chronic disease, where overweight and obese patients may have better health outcomes than lean patients [14].
Singanayagam and Chalmers have found that obesity (BMI ≥ 30) was independently associated with reduced 30‐day
mortality in patients hospitalized with community‐acquired pneumonia [15]. An alternative explanation is that
increased body thickness of obese individuals leads to limited diagnostic quality image, poor X‐ray penetration, and poor
visualization [16]. These technical difficulties associated with X‐ray imaging of obese individuals may lead to lower rates
of X‐ray diagnosed pneumonia among obese and morbidly obese.

This study had several limitations. The administration of a laboratory influenza test depends on clinician’s judgment of
patient’s symptoms [12]. This suggests that initiation of laboratory influenza testing may vary by clinician. Some
clinicians may be more likely to initiate laboratory testing, or may differentially administer tests to patients based on
patients’ clinical and demographic characteristics. Adults who were hospitalized for influenza but were not tested for
influenza by a clinician were not included in our FluSurv‐NET database[12].
A second limitation of our study was that clinical diagnoses not listed in medical record were not included in FluSurv‐NET
database[12]. This may lead to underreporting of comorbidities associated with our outcomes of interest. Another
possible limitation was that despite the inclusion of more than 9,000 cases of laboratory‐confirmed influenza in our
study, there were too few deaths (n=237) to study the association between BMI and death. Future studies may examine
the association between death and obesity among patients hospitalized for seasonal influenza.
Nevertheless, our study had a number of strengths. First, all cases in our dataset had laboratory‐confirmed influenza
diagnosis, which allowed us to examine the association between BMI and adverse outcomes, for only patients who had
confirmed seasonal influenza. Additionally, our database includes comprehensive data regarding patient comorbidities,
vaccination status, antiviral administration, and severe in‐hospital outcomes. With more than 1,500 cases in each of
obese and morbidly obese categories, we had sufficiently large numbers of observations of severe outcomes in both
obese and morbidly obese categories to create methodologically sound statistical models.
Our results suggest that severe obesity is not associated with increased risk of severe in‐hospital outcomes among
patients hospitalized for influenza during the 2012‐2013 influenza season. These findings are in contrast to Cocoros et
al.’s recent finding of a positive association between obesity and hospitalized influenza‐like illness (ILI) among adults [7].
Our findings are more aligned with Coleman et al.’s finding that obesity was not associated with medically attended
influenza among adults with acute respiratory illness [8]. Because dominant influenza strains tend to vary by flu season,
further exploration of this association during different influenza seasons or among non‐hospitalized adults may help
elucidate the association between obesity and severe seasonal influenza outcomes.
In conclusion, using data from a large and comprehensive, multisite surveillance program, we found no evidence of
increased odds of adverse influenza‐related outcomes among obese and morbidly obese adults hospitalized for seasonal
influenza. In addition, we found that overweight patients had decreased odds of adverse outcomes compared to normal
weight patients. Although it has been widely demonstrated that obese and morbidly obese adults hospitalized during
the 2009 H1N1 pandemic were at greater risk for adverse health outcomes, obese and morbidly obese patients who are
hospitalized during seasonal influenza epidemics do not appear to fare any worse than their normal weight
counterparts.

Table 1. Patient characteristics by BMI category
Overall
N = 9048*
Demographic Characteristics
Age Group
20‐49
1496 (16.53)
50‐64
1966 (21.73)
65‐74
1587 (17.54)
75‐84
2007 (22.18)
85+
1992 (22.02)
Sex
Male
4177 (46.16)
Female
4871 (53.84)
Race
White
5989 (66.19)
Black
1523 (16.83)
Hispanic
605 (6.69)
Other/
931 (10.29)
Unknown
Comorbidities
CVD
4354 (48.12)
CMD
3769 (41.66)

1)
Underweight
(BMI <18.5)

2) Normal
(BMI 18.5 to
<25)

BMI Categories
3)
4) Obese
Overweight
(BMI 30 to
(BMI 25 to
<35)
<30)

5) Morbidly
(Obese
BMI ≥35)

p‐value

62(15.01)
74 (17.92)
57 (13.80)
92 (22.28)
128 (30.99)

431 (15.14)
465 (16.33)
425 (14.93)
620 (21.78)
906 (31.82)

396 (14.66)
510 (18.88)
460 (17.03)
716 (26.51)
619 (22.92)

230 (15.07)
401 (26.28)
325 (21.30)
329 (21.56)
241 (15.79)

377 (24.15)
516 (33.06)
320 (20.50)
250 (16.02)
98 (6.28)

<.0001

142 (34.38)
271 (65.62)

1337 (46.96)
1510 (53.04)

1417 (52.46)
1284 (47.54)

709 (46.46)
817 (53.54)

572 (36.64)
989 (63.36)

<.0001

275 (66.59)
65 (15.74)
17 (4.12)
56 (13.56)

1948 (68.42)
378 (13.28)
155 (5.44)
366 (12.86)

1844 (68.27)
411 (15.22)
185 (6.85)
261 (9.66)

971 (63.63)
296 (19.40)
125 (8.19)
134 (8.78)

951 (60.92)
373 (23.89)
123 (7.88)
114 (7.30)

<.0001

163 (39.47)
126 (30.51)

1341 (47.10)
962 (33.79)

1317 (48.76)
1113 (41.21)

786 (51.51)
724 (47.44)

747 (47.85)
844 (54.07)

0.0003
<.0001

64 (4.19)

44 (2.82)

0.0054

239 (15.66)

196 (12.56)

<.0001

244 (15.99)
331 (21.69)
317 (20.77)

236 (15.12)
272 (17.42)
475 (30.43)

<.0001
0.0051
<.0001

49 (3.21)
64 (4.19)

35 (2.24)
55 (3.52)

0.0039

287 (18.81)
452 (29.62)

339 (21.72)
433 (27.74)

0.0011

707 (46.73)
513 (33.91)

722 (47.01)
545 (35.48)

0.1328

737 (51.54)

677 (46.50)

<.0001

Neuro‐
Muscular
Disorder
406 (4.49)
21 (5.08)
148 (5.20)
129 (4.78)
Neurologic
Disorder
1833 (20.26)
124 (30.02)
723 (25.40)
551 (20.40)
Immuno‐
compromised
Condition
1516 (16.76)
99 (23.97)
512 (17.98)
425 (15.73)
Renal Disease
1718 (18.99)
62 (15.01)
527 (18.51)
526 (19.47)
Asthma
1664 (18.39)
47 (11.38)
386 (13.56)
439 (16.25)
Lifestyle Factors
Alcohol Abuse
Current
321 (3.55)
21 (5.08)
124 (4.36)
92 (3.41)
Former
298 (3.29)
10 (2.42)
88 (3.09)
81 (3.00)
Smoking
Status
1755 (19.40)
106 (25.67)
555 (19.49)
468 (17.33)
Current
2551 (28.19)
102 (24.70)
783 (27.50)
781 (28.92)
Former
Patient Care Factors
Antiviral
Administra‐
tion
Prompt
4117 (46.10)
182 (44.72)
1254 (44.63)
1252 (47.00)
Late
3225 (36.11)
143 (35.14)
1049 (37.33)
975 (36.60)
Influenza
Vaccine
4495 (53.63)
194 (50.79)
1506 (57.52)
1381 (55.35)
* Numbers may not sum to totals due to missing data
Bold p‐values indicate a statistically significant chi‐square test of homogeneity.

Table 2. Unadjusted and adjusted associations between BMI category and artificial ventilation

1.105 (0.731, 1.669)

Model 2:
OR (95% CI) adjusted for
sex and age (as categorical)
1.126 (0.744, 1.705)

Model 3:
OR (95% CI) adjusted for all
covariates in Table 1
1.167 (0.752, 1.810)

Normal Weight

1

1

1

Overweight

0.905 (0.724, 1.132)

0.860 (0.687, 1.078)

0.870 (0.676, 1.120)

Obese
Morbidly Obese

1.029 (0.797, 1.329)
1.137 (0.887, 1.455)

0.927 (0.716, 1.201)
0.969 (0.751, 1.249)

1.045 (0.788, 1.386)
1.033 (0.774, 1.379)

Artificial Ventilation
n=9014

Model 1:
Unadjusted OR (95% CI)

Underweight

Table 3. Unadjusted and adjusted associations between BMI category and ICU admission
ICU Admission
n = 9017

Model 1:
Unadjusted OR (95% CI)

Underweight
Normal Weight
Overweight
Obese
Morbidly Obese

1.121 (0.854, 1.471)
1
0.838 (0.723, 0.972)
0.971 (0.819, 1.152)
1.013 (0.857, 1.198)

Model 2:
OR (95% CI) adjusted for
sex and age (as categorical)
1.135 (0.864, 1.491)
1
0.809 (0.697, 0.940)
0.906 (0.763, 1.077)
0.913 (0.768, 1.085)

Model 3:
OR (95% CI) adjusted for all
covariates in Table 1
1.055 (0.785, 1.419)
1
0.787 (0.670, 0.924)
0.892 (0.741, 1.074)
0.855 (0.706, 1.036)

Table 4. Unadjusted and adjusted associations between BMI category and X‐ray confirmed pneumonia

1.291 (1.044, 1.596)

Model 2:
OR (95% CI) adjusted for
sex and age (as categorical)
1.343 (1.085, 1.663)

Model 3:
OR (95% CI) adjusted for all
covariates in Table 1
1.330 (1.061, 1.668)

Normal Weight

1

1

1

Overweight

0.825 (0.736, 0.924)

0.831 (0.741, 0.932)

0.867 (0.768, 0.979)

Obese
0.734 (0.640, 0.841)
Morbidly Obese
0.724 (0.632, 0.829)
*n =8769 subjects who received chest X‐ray

0.775 (0.675, 0.890)
0.834 (0.724, 0.960)

0.795 (0.687, 0.921)
0.890 (0.764, 1.037)

X‐Ray Confirmed
Pneumonia
n=8769
Underweight

Model 1:
Unadjusted OR (95% CI)
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